Literature DB >> 30025758

A comparison of patient satisfaction (using the BREAST-Q questionnaire) with bilateral breast reconstruction following risk-reducing or therapeutic mastectomy.

F Kazzazi1, R Haggie1, P Forouhi2, N Kazzazi3, L Wyld4, C M Malata5.   

Abstract

INTRODUCTION: Patients undergoing mastectomy and immediate breast reconstruction for cancer may be expected to have different perceptions of long-term outcomes compared with those who have this operation prophylactically.
METHODS: Patients who underwent bilateral mastectomy and breast reconstruction from 2008 to 2014 at the Cambridge Breast Unit were identified from a prospective register and their notes were audited. They were classified according to their indication for surgery as follows: bilaterally therapeutic, bilaterally risk-reducing or combination. The BREAST-Q™ questionnaire was posted to participants using the 'total Dillman method'. Q-SCORE software was utilised to analyse patient satisfaction scores.
RESULTS: Sixty-five (58%) responses were received, of which 8 were excluded, leaving 57 usable for the study. The therapeutic group had higher patient satisfaction than the risk-reducing group across most domains including breast, outcome, psychosocial, sexual, physical and information. The combination group scored lower and BRCA gene mutation-positive patients scored the lowest. Physical well-being was maintained across all groups but psychosocial/sexual well-being varied. Good psychosocial well-being was linked to a higher satisfaction with the outcome in the combination and risk-reducing groups.
CONCLUSION: This study highlights the need for clinicians to take into account the indication for surgery as a major psychological factor in patients' perception of self and experience of surgery. It demonstrates that bilateral immediate reconstruction patients report similar physical symptoms irrespective of indication for mastectomy, but the decision-making process in terms of risk-balancing and diagnosis influences satisfaction with self and surgery. It underlines the importance of preoperative management of expectations for patients undergoing risk-reducing procedures.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Keywords:  Breast Surgery; Breast-q; Mastectomy; Patient reported outcome measures; Risk-reducing; Satisfaction

Mesh:

Year:  2018        PMID: 30025758     DOI: 10.1016/j.bjps.2018.06.011

Source DB:  PubMed          Journal:  J Plast Reconstr Aesthet Surg        ISSN: 1748-6815            Impact factor:   2.740


  6 in total

1.  The past, the present and the future of UK breast reconstruction-are our practices outdated in 2020?

Authors:  Primeera Wignarajah; Parto Forouhi; Charles M Malata
Journal:  Gland Surg       Date:  2020-08

2.  Patient Self-reported Breast Cup Size and Resultant Mastectomy Specimen Weight: Implications for Reconstructive Breast Surgery.

Authors:  Kevin Perez; Sumeet S Teotia; Nicholas T Haddock
Journal:  Plast Reconstr Surg Glob Open       Date:  2022-07-11

3.  Current Trends in Breast Reconstruction following Bilateral Prophylactic Mastectomy.

Authors:  Vivian J Hu; Sean P McCleary; Carolyn P Smullin; Ricardo Rosales Morales; Andrew L Da Lio
Journal:  Plast Reconstr Surg Glob Open       Date:  2022-04-18

4.  Patient-Reported Satisfaction after Prophylactic Operations of the Breast.

Authors:  Katja Keller; Cornelia Meisel; Nannette Grübling; Andrea Petzold; Pauline Wimberger; Karin Kast
Journal:  Breast Care (Basel)       Date:  2019-02-15       Impact factor: 2.860

5.  Analysis of Secondary Surgeries after Immediate Breast Reconstruction for Cancer Compared with Risk Reduction.

Authors:  Stacey J Jones; Philip Turton; Rajgopal Achuthan; Brian V Hogan; Shireen N Mckenzie; Baek Kim
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-12-17

6.  Satisfaction and Quality of Life of Healthy and Unilateral Diseased BRCA1/2 Pathogenic Variant Carriers after Risk-Reducing Mastectomy and Reconstruction Using the BREAST-Q Questionnaire.

Authors:  Natalie Herold; Martin Hellmich; Frank Lichtenheldt; Beyhan Ataseven; Vanessa Hillebrand; Barbara Wappenschmidt; Rita Katharina Schmutzler; Kerstin Rhiem
Journal:  Genes (Basel)       Date:  2022-07-28       Impact factor: 4.141

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.